

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.97953893 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.42286475 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.42286475 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.18168182 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.18168182 |
| 6 | omega-hydroxylase P450 pathway (GO:0097267) | 7.09292792 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.91538338 |
| 8 | glyoxylate metabolic process (GO:0046487) | 6.51248268 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.43043615 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.43043615 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.43043615 |
| 12 | cysteine metabolic process (GO:0006534) | 6.21622848 |
| 13 | lysine metabolic process (GO:0006553) | 6.21275992 |
| 14 | lysine catabolic process (GO:0006554) | 6.21275992 |
| 15 | ethanol metabolic process (GO:0006067) | 6.09457181 |
| 16 | kynurenine metabolic process (GO:0070189) | 6.08860612 |
| 17 | tryptophan metabolic process (GO:0006568) | 6.05875858 |
| 18 | urate metabolic process (GO:0046415) | 5.54319886 |
| 19 | drug transmembrane transport (GO:0006855) | 5.50233001 |
| 20 | primary alcohol catabolic process (GO:0034310) | 5.49062171 |
| 21 | serine family amino acid catabolic process (GO:0009071) | 5.43318783 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.38790747 |
| 23 | fibrinolysis (GO:0042730) | 5.31055892 |
| 24 | homocysteine metabolic process (GO:0050667) | 5.27734593 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.26495964 |
| 26 | * bile acid biosynthetic process (GO:0006699) | 5.24196688 |
| 27 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.19490046 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 5.17995452 |
| 29 | amino-acid betaine metabolic process (GO:0006577) | 5.07146976 |
| 30 | axonemal dynein complex assembly (GO:0070286) | 5.06066510 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 5.04924858 |
| 32 | blood coagulation, intrinsic pathway (GO:0007597) | 5.03909779 |
| 33 | urea cycle (GO:0000050) | 4.99428173 |
| 34 | urea metabolic process (GO:0019627) | 4.99428173 |
| 35 | oxidative demethylation (GO:0070989) | 4.89415664 |
| 36 | drug catabolic process (GO:0042737) | 4.84686645 |
| 37 | cellular ketone body metabolic process (GO:0046950) | 4.84125571 |
| 38 | alpha-amino acid catabolic process (GO:1901606) | 4.77483063 |
| 39 | serine family amino acid metabolic process (GO:0009069) | 4.65363895 |
| 40 | nitrogen cycle metabolic process (GO:0071941) | 4.64057349 |
| 41 | drug transport (GO:0015893) | 4.62502664 |
| 42 | glutamate metabolic process (GO:0006536) | 4.59922361 |
| 43 | indolalkylamine metabolic process (GO:0006586) | 4.55336061 |
| 44 | negative regulation of fibrinolysis (GO:0051918) | 4.55165384 |
| 45 | cellular modified amino acid catabolic process (GO:0042219) | 4.55135132 |
| 46 | regulation of humoral immune response (GO:0002920) | 4.53736219 |
| 47 | short-chain fatty acid metabolic process (GO:0046459) | 4.51782490 |
| 48 | phenylpropanoid metabolic process (GO:0009698) | 4.51474813 |
| 49 | tyrosine metabolic process (GO:0006570) | 4.51275299 |
| 50 | cellular amino acid catabolic process (GO:0009063) | 4.50285433 |
| 51 | protein carboxylation (GO:0018214) | 4.49866945 |
| 52 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.49866945 |
| 53 | high-density lipoprotein particle remodeling (GO:0034375) | 4.49238541 |
| 54 | protein activation cascade (GO:0072376) | 4.48165910 |
| 55 | * bile acid metabolic process (GO:0008206) | 4.47608423 |
| 56 | aspartate family amino acid catabolic process (GO:0009068) | 4.41746999 |
| 57 | complement activation, classical pathway (GO:0006958) | 4.38661016 |
| 58 | cellular biogenic amine catabolic process (GO:0042402) | 4.38193802 |
| 59 | amine catabolic process (GO:0009310) | 4.38193802 |
| 60 | regulation of fibrinolysis (GO:0051917) | 4.35171688 |
| 61 | complement activation, alternative pathway (GO:0006957) | 4.35006372 |
| 62 | exogenous drug catabolic process (GO:0042738) | 4.34803227 |
| 63 | benzene-containing compound metabolic process (GO:0042537) | 4.33256833 |
| 64 | regulation of protein activation cascade (GO:2000257) | 4.30334751 |
| 65 | complement activation (GO:0006956) | 4.28100165 |
| 66 | serine family amino acid biosynthetic process (GO:0009070) | 4.27115936 |
| 67 | cellular glucuronidation (GO:0052695) | 4.22555419 |
| 68 | negative regulation of protein activation cascade (GO:2000258) | 4.21536459 |
| 69 | acetyl-CoA metabolic process (GO:0006084) | 4.20254663 |
| 70 | glycine metabolic process (GO:0006544) | 4.19732335 |
| 71 | ketone body metabolic process (GO:1902224) | 4.18744735 |
| 72 | negative regulation of cholesterol transport (GO:0032375) | 4.16134126 |
| 73 | negative regulation of sterol transport (GO:0032372) | 4.16134126 |
| 74 | 2-oxoglutarate metabolic process (GO:0006103) | 4.15939173 |
| 75 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.13263347 |
| 76 | acute-phase response (GO:0006953) | 4.11028457 |
| 77 | negative regulation of hemostasis (GO:1900047) | 4.08154396 |
| 78 | negative regulation of blood coagulation (GO:0030195) | 4.08154396 |
| 79 | daunorubicin metabolic process (GO:0044597) | 4.07860620 |
| 80 | polyketide metabolic process (GO:0030638) | 4.07860620 |
| 81 | doxorubicin metabolic process (GO:0044598) | 4.07860620 |
| 82 | coenzyme catabolic process (GO:0009109) | 4.07489978 |
| 83 | regulation of triglyceride catabolic process (GO:0010896) | 4.06698781 |
| 84 | aldehyde catabolic process (GO:0046185) | 4.05007656 |
| 85 | regulation of complement activation (GO:0030449) | 4.01872202 |
| 86 | acylglycerol homeostasis (GO:0055090) | 4.01321581 |
| 87 | triglyceride homeostasis (GO:0070328) | 4.01321581 |
| 88 | regulation of plasminogen activation (GO:0010755) | 4.00369857 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00316422 |
| 90 | ethanol oxidation (GO:0006069) | 4.00007791 |
| 91 | * organic acid catabolic process (GO:0016054) | 3.97003834 |
| 92 | * carboxylic acid catabolic process (GO:0046395) | 3.97003834 |
| 93 | response to mercury ion (GO:0046689) | 3.96997085 |
| 94 | carnitine metabolic process (GO:0009437) | 3.96560276 |
| 95 | hormone catabolic process (GO:0042447) | 3.95532688 |
| 96 | regulation of cholesterol esterification (GO:0010872) | 3.94802414 |
| 97 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.94016506 |
| 98 | reverse cholesterol transport (GO:0043691) | 3.92932969 |
| 99 | glucuronate metabolic process (GO:0019585) | 3.91886628 |
| 100 | uronic acid metabolic process (GO:0006063) | 3.91886628 |
| 101 | protein-lipid complex remodeling (GO:0034368) | 3.88304454 |
| 102 | macromolecular complex remodeling (GO:0034367) | 3.88304454 |
| 103 | plasma lipoprotein particle remodeling (GO:0034369) | 3.88304454 |
| 104 | bile acid and bile salt transport (GO:0015721) | 3.85102314 |
| 105 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.84079024 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.84079024 |
| 107 | valine metabolic process (GO:0006573) | 3.82969288 |
| 108 | * fatty acid beta-oxidation (GO:0006635) | 3.81107543 |
| 109 | * fatty acid oxidation (GO:0019395) | 3.80423160 |
| 110 | heme transport (GO:0015886) | 3.74544762 |
| 111 | * lipid oxidation (GO:0034440) | 3.72926741 |
| 112 | regulation of cholesterol homeostasis (GO:2000188) | 3.71487082 |
| 113 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.70277426 |
| 114 | cytolysis (GO:0019835) | 3.69659410 |
| 115 | negative regulation of coagulation (GO:0050819) | 3.69475649 |
| 116 | arginine metabolic process (GO:0006525) | 3.68688955 |
| 117 | * monocarboxylic acid catabolic process (GO:0072329) | 3.68182819 |
| 118 | negative regulation of humoral immune response (GO:0002921) | 3.67434126 |
| 119 | cholesterol efflux (GO:0033344) | 3.65297101 |
| 120 | phospholipid efflux (GO:0033700) | 3.64899789 |
| 121 | imidazole-containing compound metabolic process (GO:0052803) | 3.64043772 |
| 122 | drug metabolic process (GO:0017144) | 3.63286734 |
| 123 | proline metabolic process (GO:0006560) | 3.61052410 |
| 124 | negative regulation of wound healing (GO:0061045) | 3.60772642 |
| 125 | plasma lipoprotein particle clearance (GO:0034381) | 3.60453877 |
| 126 | intestinal cholesterol absorption (GO:0030299) | 3.58869642 |
| 127 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.58778093 |
| 128 | primary alcohol metabolic process (GO:0034308) | 3.58536452 |
| 129 | branched-chain amino acid metabolic process (GO:0009081) | 3.57456062 |
| 130 | flavonoid metabolic process (GO:0009812) | 3.57337880 |
| 131 | xenobiotic metabolic process (GO:0006805) | 3.56834354 |
| 132 | regulation of bile acid biosynthetic process (GO:0070857) | 3.56449335 |
| 133 | * fatty acid catabolic process (GO:0009062) | 3.56350314 |
| 134 | regulation of apoptotic cell clearance (GO:2000425) | 3.54500880 |
| 135 | organic cation transport (GO:0015695) | 3.53415159 |
| 136 | phosphate ion transport (GO:0006817) | 3.52060220 |
| 137 | S-adenosylmethionine metabolic process (GO:0046500) | 3.51925125 |
| 138 | opsonization (GO:0008228) | 3.51870685 |
| 139 | branched-chain amino acid catabolic process (GO:0009083) | 3.48468597 |
| 140 | diterpenoid biosynthetic process (GO:0016102) | 3.44624629 |
| 141 | motile cilium assembly (GO:0044458) | 3.44180789 |
| 142 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.43932541 |
| 143 | response to nitrosative stress (GO:0051409) | 3.43507997 |
| 144 | indole-containing compound metabolic process (GO:0042430) | 3.43038674 |
| 145 | negative regulation of lipase activity (GO:0060192) | 3.39214404 |
| 146 | negative regulation of complement activation (GO:0045916) | 3.38594158 |
| 147 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.35847076 |
| 148 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.35847076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.20809258 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.01868639 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.33957470 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.32471758 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.01660527 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.92455428 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.51555117 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.87355549 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.73602625 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.79605570 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.57628405 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.33212742 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.29768419 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.15975199 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4346418 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73792307 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66367653 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.53160933 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46121012 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34709186 |
| 21 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24042828 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22753537 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18431201 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16493231 |
| 25 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15758144 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15649501 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15035463 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14830141 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13383329 |
| 30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12905653 |
| 31 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10820779 |
| 32 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10626561 |
| 33 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10334201 |
| 34 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.09354354 |
| 35 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.07683569 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06483716 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05757619 |
| 38 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04956859 |
| 39 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.04691440 |
| 40 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04029179 |
| 41 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03898773 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02676496 |
| 43 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00045953 |
| 44 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98565342 |
| 45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91689692 |
| 46 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91082133 |
| 47 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.88490883 |
| 48 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88062030 |
| 49 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87935310 |
| 50 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.86449292 |
| 51 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86089570 |
| 52 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.85568482 |
| 53 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.83141907 |
| 54 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.83050220 |
| 55 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.82384089 |
| 56 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80725647 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 0.80618625 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80558667 |
| 59 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80358537 |
| 60 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.79947415 |
| 61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79125603 |
| 62 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.78348831 |
| 63 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.78032879 |
| 64 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76968579 |
| 65 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76968515 |
| 66 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74196507 |
| 67 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.73527650 |
| 68 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73375001 |
| 69 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.72898937 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72615280 |
| 71 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72287081 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.72116367 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.71969177 |
| 74 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71812927 |
| 75 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.71410663 |
| 76 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.71367872 |
| 77 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.70614571 |
| 78 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68944835 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.68892391 |
| 80 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68379072 |
| 81 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.68118730 |
| 82 | P300_27268052_Chip-Seq_Bcells_Human | 0.67933533 |
| 83 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67782075 |
| 84 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.67049543 |
| 85 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.67047701 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.66719973 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66316264 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66316264 |
| 89 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.65404075 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.64657933 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.64540404 |
| 92 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.64236772 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.64130053 |
| 94 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.62949005 |
| 95 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.62467622 |
| 96 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62159474 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.61870929 |
| 98 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61714394 |
| 99 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.61403742 |
| 100 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.61346639 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.61044664 |
| 102 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.60637617 |
| 103 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.58970710 |
| 104 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.58407452 |
| 105 | AR_20517297_ChIP-Seq_VCAP_Human | 0.57510492 |
| 106 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.56636235 |
| 107 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.54780279 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.54545748 |
| 109 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53901062 |
| 110 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53313461 |
| 111 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52293938 |
| 112 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51727770 |
| 113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50771711 |
| 114 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.50718050 |
| 115 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.50559781 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50556533 |
| 117 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.50173144 |
| 118 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.48985494 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48401833 |
| 120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.47267919 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.47163918 |
| 122 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.47122281 |
| 123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.47087614 |
| 124 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.46780384 |
| 125 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46202279 |
| 126 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45896239 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.44875227 |
| 128 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44427529 |
| 129 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.44385403 |
| 130 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.44342122 |
| 131 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.43916522 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.43406115 |
| 133 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.43240952 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42584924 |
| 135 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41915227 |
| 136 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.40981160 |
| 137 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.40760307 |
| 138 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.40652982 |
| 139 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.40582257 |
| 140 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40562478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.24934935 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.96426307 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.77642574 |
| 4 | MP0005365_abnormal_bile_salt | 5.65508950 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.97894390 |
| 6 | MP0003252_abnormal_bile_duct | 3.85758173 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.77873230 |
| 8 | MP0005332_abnormal_amino_acid | 3.62617697 |
| 9 | MP0003195_calcinosis | 3.49453119 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 3.13604368 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.07290974 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.69640528 |
| 13 | MP0009840_abnormal_foam_cell | 2.54678228 |
| 14 | MP0005083_abnormal_biliary_tract | 2.47905985 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.40394984 |
| 16 | MP0002132_abnormal_respiratory_system | 2.29078556 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.14854999 |
| 18 | MP0009643_abnormal_urine_homeostasis | 2.11463567 |
| 19 | MP0004043_abnormal_pH_regulation | 1.96116465 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.93335079 |
| 21 | MP0000609_abnormal_liver_physiology | 1.90420443 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.83540128 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.70109833 |
| 24 | MP0001764_abnormal_homeostasis | 1.63829869 |
| 25 | MP0005636_abnormal_mineral_homeostasis | 1.62242173 |
| 26 | MP0005451_abnormal_body_composition | 1.60543453 |
| 27 | MP0003868_abnormal_feces_composition | 1.52058102 |
| 28 | MP0003186_abnormal_redox_activity | 1.51592317 |
| 29 | MP0001756_abnormal_urination | 1.41828710 |
| 30 | MP0002136_abnormal_kidney_physiology | 1.21081957 |
| 31 | MP0001765_abnormal_ion_homeostasis | 1.18979528 |
| 32 | MP0000598_abnormal_liver_morphology | 1.07682007 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.02335696 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.01608992 |
| 35 | MP0009764_decreased_sensitivity_to | 1.01140346 |
| 36 | MP0005084_abnormal_gallbladder_morpholo | 1.01060697 |
| 37 | MP0009697_abnormal_copulation | 0.96727830 |
| 38 | MP0005670_abnormal_white_adipose | 0.96046160 |
| 39 | MP0003011_delayed_dark_adaptation | 0.93663844 |
| 40 | MP0005647_abnormal_sex_gland | 0.93341842 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 0.91587190 |
| 42 | MP0009642_abnormal_blood_homeostasis | 0.89885937 |
| 43 | MP0010155_abnormal_intestine_physiology | 0.89425537 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 0.88011137 |
| 45 | MP0000604_amyloidosis | 0.87477921 |
| 46 | MP0005535_abnormal_body_temperature | 0.84068539 |
| 47 | MP0008469_abnormal_protein_level | 0.83192167 |
| 48 | MP0000566_synostosis | 0.80882078 |
| 49 | MP0005408_hypopigmentation | 0.80727236 |
| 50 | MP0009763_increased_sensitivity_to | 0.79692784 |
| 51 | MP0001661_extended_life_span | 0.76756224 |
| 52 | MP0005220_abnormal_exocrine_pancreas | 0.75819101 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 0.75299102 |
| 54 | MP0002928_abnormal_bile_duct | 0.75088265 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 0.73467721 |
| 56 | MP0005058_abnormal_lysosome_morphology | 0.71971925 |
| 57 | MP0005376_homeostasis/metabolism_phenot | 0.70944377 |
| 58 | MP0000678_abnormal_parathyroid_gland | 0.68887156 |
| 59 | MP0002254_reproductive_system_inflammat | 0.68235536 |
| 60 | MP0009765_abnormal_xenobiotic_induced | 0.68119159 |
| 61 | MP0001915_intracranial_hemorrhage | 0.65216564 |
| 62 | MP0001881_abnormal_mammary_gland | 0.64574251 |
| 63 | MP0002971_abnormal_brown_adipose | 0.64304840 |
| 64 | MP0001873_stomach_inflammation | 0.63611627 |
| 65 | MP0006035_abnormal_mitochondrial_morpho | 0.62037066 |
| 66 | MP0002168_other_aberrant_phenotype | 0.60604696 |
| 67 | MP0000230_abnormal_systemic_arterial | 0.60362227 |
| 68 | MP0003638_abnormal_response/metabolism_ | 0.60295227 |
| 69 | MP0000538_abnormal_urinary_bladder | 0.60141542 |
| 70 | MP0005395_other_phenotype | 0.59247402 |
| 71 | MP0003329_amyloid_beta_deposits | 0.58907950 |
| 72 | MP0002249_abnormal_larynx_morphology | 0.58577242 |
| 73 | MP0003693_abnormal_embryo_hatching | 0.57756853 |
| 74 | MP0010368_abnormal_lymphatic_system | 0.57095236 |
| 75 | MP0005334_abnormal_fat_pad | 0.56684400 |
| 76 | MP0005266_abnormal_metabolism | 0.56661994 |
| 77 | MP0005666_abnormal_adipose_tissue | 0.56400343 |
| 78 | MP0002282_abnormal_trachea_morphology | 0.54628539 |
| 79 | MP0000467_abnormal_esophagus_morphology | 0.54164032 |
| 80 | MP0003690_abnormal_glial_cell | 0.52696697 |
| 81 | MP0008961_abnormal_basal_metabolism | 0.52161137 |
| 82 | MP0009053_abnormal_anal_canal | 0.52092607 |
| 83 | MP0004130_abnormal_muscle_cell | 0.51827643 |
| 84 | MP0001545_abnormal_hematopoietic_system | 0.50003156 |
| 85 | MP0005397_hematopoietic_system_phenotyp | 0.50003156 |
| 86 | MP0003300_gastrointestinal_ulcer | 0.49396504 |
| 87 | MP0002135_abnormal_kidney_morphology | 0.48908266 |
| 88 | MP0000477_abnormal_intestine_morphology | 0.48636959 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.48479335 |
| 90 | MP0002796_impaired_skin_barrier | 0.45362012 |
| 91 | MP0003953_abnormal_hormone_level | 0.44980639 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 0.44891302 |
| 93 | MP0004264_abnormal_extraembryonic_tissu | 0.43879343 |
| 94 | MP0004957_abnormal_blastocyst_morpholog | 0.42880316 |
| 95 | MP0009379_abnormal_foot_pigmentation | 0.41681354 |
| 96 | MP0009333_abnormal_splenocyte_physiolog | 0.41421377 |
| 97 | MP0003866_abnormal_defecation | 0.41111317 |
| 98 | MP0005187_abnormal_penis_morphology | 0.40634346 |
| 99 | MP0003878_abnormal_ear_physiology | 0.40620851 |
| 100 | MP0005377_hearing/vestibular/ear_phenot | 0.40620851 |
| 101 | MP0003724_increased_susceptibility_to | 0.38343168 |
| 102 | MP0008874_decreased_physiological_sensi | 0.37625857 |
| 103 | MP0001727_abnormal_embryo_implantation | 0.36947120 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 0.36773759 |
| 105 | MP0004185_abnormal_adipocyte_glucose | 0.36525921 |
| 106 | MP0009672_abnormal_birth_weight | 0.36521691 |
| 107 | MP0005023_abnormal_wound_healing | 0.36437789 |
| 108 | MP0005448_abnormal_energy_balance | 0.36244212 |
| 109 | MP0008872_abnormal_physiological_respon | 0.36103670 |
| 110 | MP0005166_decreased_susceptibility_to | 0.35794999 |
| 111 | MP0003075_altered_response_to | 0.35789184 |
| 112 | MP0010234_abnormal_vibrissa_follicle | 0.35142100 |
| 113 | MP0000858_altered_metastatic_potential | 0.35079390 |
| 114 | MP0003718_maternal_effect | 0.34903364 |
| 115 | MP0004147_increased_porphyrin_level | 0.34900953 |
| 116 | MP0008873_increased_physiological_sensi | 0.34566255 |
| 117 | MP0000490_abnormal_crypts_of | 0.34533474 |
| 118 | MP0002098_abnormal_vibrissa_morphology | 0.34401495 |
| 119 | MP0001730_embryonic_growth_arrest | 0.33578340 |
| 120 | MP0005165_increased_susceptibility_to | 0.33118290 |
| 121 | MP0003959_abnormal_lean_body | 0.32662410 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.32427620 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.30890931 |
| 124 | MP0002837_dystrophic_cardiac_calcinosis | 0.27885724 |
| 125 | MP0001958_emphysema | 0.27416695 |
| 126 | MP0009115_abnormal_fat_cell | 0.27409745 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.26741076 |
| 128 | MP0005464_abnormal_platelet_physiology | 0.26736926 |
| 129 | MP0002822_catalepsy | 0.25360203 |
| 130 | MP0004885_abnormal_endolymph | 0.24766804 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.24745023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.45720780 |
| 2 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 6.08641974 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.98446899 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.62923080 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.47723931 |
| 6 | Xanthomatosis (HP:0000991) | 5.38311970 |
| 7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.10816705 |
| 8 | Abnormal respiratory motile cilium physiology (HP:0012261) | 5.07830315 |
| 9 | Hyperglycinuria (HP:0003108) | 5.07042409 |
| 10 | Abnormal respiratory motile cilium morphology (HP:0005938) | 5.01371126 |
| 11 | Abnormal respiratory epithelium morphology (HP:0012253) | 5.01371126 |
| 12 | Rhinitis (HP:0012384) | 4.86757614 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 4.82505640 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 4.76517827 |
| 15 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.74999722 |
| 16 | Absent/shortened dynein arms (HP:0200106) | 4.74999722 |
| 17 | Gout (HP:0001997) | 4.74364196 |
| 18 | Abnormal ciliary motility (HP:0012262) | 4.74080131 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.68174720 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 4.68174720 |
| 21 | Ketosis (HP:0001946) | 4.63394183 |
| 22 | Hyperglycinemia (HP:0002154) | 4.55050042 |
| 23 | Hyperammonemia (HP:0001987) | 4.53766380 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.38104525 |
| 25 | Glomerulonephritis (HP:0000099) | 4.23736692 |
| 26 | Hyperlipoproteinemia (HP:0010980) | 4.21113176 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.16168956 |
| 28 | Complement deficiency (HP:0004431) | 3.92659856 |
| 29 | Ketoacidosis (HP:0001993) | 3.91694338 |
| 30 | Chronic bronchitis (HP:0004469) | 3.91008869 |
| 31 | Abnormality of purine metabolism (HP:0004352) | 3.88522298 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.84955284 |
| 33 | Joint hemorrhage (HP:0005261) | 3.81065272 |
| 34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.68003286 |
| 35 | Hypolipoproteinemia (HP:0010981) | 3.62816742 |
| 36 | Proximal tubulopathy (HP:0000114) | 3.57884808 |
| 37 | Epidermoid cyst (HP:0200040) | 3.54370847 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.53948972 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.53480478 |
| 40 | Bronchiectasis (HP:0002110) | 3.48410536 |
| 41 | Abnormality of methionine metabolism (HP:0010901) | 3.47642641 |
| 42 | Fat malabsorption (HP:0002630) | 3.44410548 |
| 43 | Hyperuricemia (HP:0002149) | 3.43891879 |
| 44 | Increased purine levels (HP:0004368) | 3.43891879 |
| 45 | Alkalosis (HP:0001948) | 3.39599630 |
| 46 | Abnormality of the common coagulation pathway (HP:0010990) | 3.34663048 |
| 47 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.32058859 |
| 48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.30209733 |
| 49 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.26965261 |
| 50 | Nasal polyposis (HP:0100582) | 3.22456010 |
| 51 | Hypoalphalipoproteinemia (HP:0003233) | 3.20128813 |
| 52 | Hypokalemic alkalosis (HP:0001949) | 3.18991867 |
| 53 | Generalized aminoaciduria (HP:0002909) | 3.18734117 |
| 54 | Metabolic acidosis (HP:0001942) | 3.10953300 |
| 55 | Increased circulating renin level (HP:0000848) | 3.06546909 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 3.05774566 |
| 57 | Abnormality of serum amino acid levels (HP:0003112) | 3.05170025 |
| 58 | Nephritis (HP:0000123) | 3.03740536 |
| 59 | Vascular calcification (HP:0004934) | 2.99405692 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.98484956 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.98484956 |
| 62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.98476294 |
| 63 | Hyperactive renin-angiotensin system (HP:0000841) | 2.96606903 |
| 64 | Metabolic alkalosis (HP:0200114) | 2.88439334 |
| 65 | Hyperbilirubinemia (HP:0002904) | 2.87676136 |
| 66 | Lethargy (HP:0001254) | 2.84692332 |
| 67 | Hepatocellular carcinoma (HP:0001402) | 2.83060041 |
| 68 | Abnormality of complement system (HP:0005339) | 2.78527453 |
| 69 | Abnormality of the intrinsic pathway (HP:0010989) | 2.78245055 |
| 70 | Abnormality of urine glucose concentration (HP:0011016) | 2.76294421 |
| 71 | Glycosuria (HP:0003076) | 2.76294421 |
| 72 | Hypercholesterolemia (HP:0003124) | 2.74164395 |
| 73 | Abnormal urine output (HP:0012590) | 2.68638145 |
| 74 | Malnutrition (HP:0004395) | 2.68340891 |
| 75 | Hemorrhage of the eye (HP:0011885) | 2.67383899 |
| 76 | Cardiovascular calcification (HP:0011915) | 2.65038979 |
| 77 | Abnormality of proline metabolism (HP:0010907) | 2.63431678 |
| 78 | Hydroxyprolinuria (HP:0003080) | 2.63431678 |
| 79 | Hypomagnesemia (HP:0002917) | 2.60594055 |
| 80 | Polyuria (HP:0000103) | 2.58578697 |
| 81 | Enlarged kidneys (HP:0000105) | 2.57821243 |
| 82 | Abnormality of the nasal mucosa (HP:0000433) | 2.56005687 |
| 83 | Vomiting (HP:0002013) | 2.54517058 |
| 84 | Steatorrhea (HP:0002570) | 2.54386011 |
| 85 | Rickets (HP:0002748) | 2.52238541 |
| 86 | Abnormality of chloride homeostasis (HP:0011422) | 2.52012234 |
| 87 | Irritability (HP:0000737) | 2.49866245 |
| 88 | Abnormality of renal excretion (HP:0011036) | 2.45138489 |
| 89 | Spastic diplegia (HP:0001264) | 2.43661478 |
| 90 | Neonatal onset (HP:0003623) | 2.43181988 |
| 91 | Cerebral edema (HP:0002181) | 2.37637796 |
| 92 | Osteomalacia (HP:0002749) | 2.28971414 |
| 93 | Sensorimotor neuropathy (HP:0007141) | 2.27502587 |
| 94 | Gingival bleeding (HP:0000225) | 2.26187878 |
| 95 | Nephrolithiasis (HP:0000787) | 2.24863852 |
| 96 | Myocardial infarction (HP:0001658) | 2.21231164 |
| 97 | Late onset (HP:0003584) | 2.20039567 |
| 98 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.20002385 |
| 99 | Systemic lupus erythematosus (HP:0002725) | 2.19436341 |
| 100 | Purpura (HP:0000979) | 2.18803970 |
| 101 | Cholecystitis (HP:0001082) | 2.18433296 |
| 102 | Abnormal gallbladder physiology (HP:0012438) | 2.18433296 |
| 103 | Renal tubular acidosis (HP:0001947) | 2.17994788 |
| 104 | Reduced antithrombin III activity (HP:0001976) | 2.15666596 |
| 105 | Recurrent otitis media (HP:0000403) | 2.15550453 |
| 106 | Hyperphosphaturia (HP:0003109) | 2.14726912 |
| 107 | Abnormality of magnesium homeostasis (HP:0004921) | 2.14328664 |
| 108 | Spontaneous abortion (HP:0005268) | 2.13163235 |
| 109 | Male infertility (HP:0003251) | 2.13086577 |
| 110 | Bronchitis (HP:0012387) | 2.12323091 |
| 111 | Confusion (HP:0001289) | 2.12048843 |
| 112 | Pancreatitis (HP:0001733) | 2.11746594 |
| 113 | Increased serum ferritin (HP:0003281) | 2.11355735 |
| 114 | Recurrent sinusitis (HP:0011108) | 2.11344702 |
| 115 | Skin nodule (HP:0200036) | 2.11328552 |
| 116 | Abnormality of vitamin metabolism (HP:0100508) | 2.09241404 |
| 117 | Thrombophlebitis (HP:0004418) | 2.08472220 |
| 118 | Hypochromic microcytic anemia (HP:0004840) | 2.06284911 |
| 119 | Cholelithiasis (HP:0001081) | 2.05559455 |
| 120 | Hypoglycemic seizures (HP:0002173) | 2.04616941 |
| 121 | Infertility (HP:0000789) | 2.04108954 |
| 122 | Hypophosphatemic rickets (HP:0004912) | 2.03776196 |
| 123 | Mitral stenosis (HP:0001718) | 2.00449211 |
| 124 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.98586262 |
| 125 | Nausea (HP:0002018) | 1.95027394 |
| 126 | Bifid scrotum (HP:0000048) | 1.94471818 |
| 127 | Abnormal drinking behavior (HP:0030082) | 1.92965755 |
| 128 | Polydipsia (HP:0001959) | 1.92965755 |
| 129 | Acanthocytosis (HP:0001927) | 1.91961317 |
| 130 | Elevated alkaline phosphatase (HP:0003155) | 1.91849380 |
| 131 | Flat acetabular roof (HP:0003180) | 1.91253376 |
| 132 | Abnormality of iron homeostasis (HP:0011031) | 1.89147115 |
| 133 | Renal salt wasting (HP:0000127) | 1.88873198 |
| 134 | Esophageal varix (HP:0002040) | 1.88847590 |
| 135 | Hypophosphatemia (HP:0002148) | 1.88511893 |
| 136 | Opisthotonus (HP:0002179) | 1.88252952 |
| 137 | Abnormal gallbladder morphology (HP:0012437) | 1.86667257 |
| 138 | Abnormal biliary tract physiology (HP:0012439) | 1.84498787 |
| 139 | Bile duct proliferation (HP:0001408) | 1.84498787 |
| 140 | Abnormality of the Achilles tendon (HP:0005109) | 1.82178036 |
| 141 | Poikilocytosis (HP:0004447) | 1.78677488 |
| 142 | Increased serum pyruvate (HP:0003542) | 1.75229295 |
| 143 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73354393 |
| 144 | Reticulocytosis (HP:0001923) | 1.72975617 |
| 145 | Abnormal tarsal ossification (HP:0008369) | 1.72428604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.68014952 |
| 2 | WNK3 | 5.19028737 |
| 3 | WNK4 | 4.77540998 |
| 4 | OXSR1 | 4.25197681 |
| 5 | FGFR4 | 3.62993394 |
| 6 | MST4 | 3.60424981 |
| 7 | SCYL2 | 3.47379415 |
| 8 | EPHA2 | 3.44415101 |
| 9 | ERN1 | 3.16965961 |
| 10 | EEF2K | 3.10997625 |
| 11 | SIK1 | 3.06056315 |
| 12 | SMG1 | 2.57787235 |
| 13 | TTK | 2.54524497 |
| 14 | PBK | 2.46001957 |
| 15 | INSRR | 2.31593459 |
| 16 | EIF2AK1 | 2.26707369 |
| 17 | MST1R | 2.18532337 |
| 18 | STK38L | 2.14750283 |
| 19 | ERBB4 | 2.10193776 |
| 20 | MAPKAPK3 | 2.03366998 |
| 21 | STK39 | 1.94623243 |
| 22 | RPS6KB2 | 1.90284313 |
| 23 | TAOK3 | 1.78603969 |
| 24 | MAP2K4 | 1.64682626 |
| 25 | NME1 | 1.63107156 |
| 26 | TSSK6 | 1.60622771 |
| 27 | NME2 | 1.58906611 |
| 28 | MAPK11 | 1.58903617 |
| 29 | PKN2 | 1.43971532 |
| 30 | PDK3 | 1.41325556 |
| 31 | PDK4 | 1.41325556 |
| 32 | PINK1 | 1.38322543 |
| 33 | PIK3CA | 1.36310758 |
| 34 | SGK223 | 1.36043491 |
| 35 | SGK494 | 1.36043491 |
| 36 | SRPK1 | 1.35298197 |
| 37 | ICK | 1.30835228 |
| 38 | LATS1 | 1.29538584 |
| 39 | TRIB3 | 1.27949278 |
| 40 | ABL2 | 1.25584172 |
| 41 | FRK | 1.24341836 |
| 42 | PIK3CG | 1.20561736 |
| 43 | GRK6 | 1.17954075 |
| 44 | MAP3K7 | 1.17943929 |
| 45 | PTK6 | 1.17372153 |
| 46 | MAP3K12 | 1.15077075 |
| 47 | NEK6 | 1.15042279 |
| 48 | NEK1 | 1.14921047 |
| 49 | SGK3 | 1.09817932 |
| 50 | FLT3 | 1.09300302 |
| 51 | DAPK2 | 1.07586068 |
| 52 | PIM2 | 1.07515479 |
| 53 | TYK2 | 1.06025209 |
| 54 | EIF2AK3 | 1.02775463 |
| 55 | PRKAA2 | 1.01491829 |
| 56 | SGK2 | 1.01157729 |
| 57 | STK16 | 1.00749130 |
| 58 | MAP3K3 | 0.99740007 |
| 59 | BRSK2 | 0.97642835 |
| 60 | NEK9 | 0.94870113 |
| 61 | PRPF4B | 0.91189294 |
| 62 | PDK2 | 0.91035203 |
| 63 | JAK2 | 0.90083893 |
| 64 | EPHB1 | 0.88337345 |
| 65 | GSK3A | 0.87520060 |
| 66 | TIE1 | 0.87035133 |
| 67 | KDR | 0.85495905 |
| 68 | MAP2K3 | 0.83189411 |
| 69 | CDC7 | 0.82582333 |
| 70 | PRKCZ | 0.80579841 |
| 71 | FGFR2 | 0.80042580 |
| 72 | DYRK1B | 0.79984495 |
| 73 | CDK12 | 0.79763576 |
| 74 | PRKAA1 | 0.79301642 |
| 75 | MAP3K14 | 0.78778730 |
| 76 | MAPK15 | 0.77724286 |
| 77 | STK38 | 0.76814399 |
| 78 | ACVR1B | 0.76338061 |
| 79 | MET | 0.75830992 |
| 80 | MAP3K10 | 0.75516937 |
| 81 | TRPM7 | 0.74577995 |
| 82 | MAP2K2 | 0.72890029 |
| 83 | ERBB2 | 0.69660415 |
| 84 | TGFBR2 | 0.67042348 |
| 85 | MAPK4 | 0.66338771 |
| 86 | PTK2 | 0.66210479 |
| 87 | PRKACG | 0.62568100 |
| 88 | PDPK1 | 0.61436681 |
| 89 | CDK7 | 0.60664052 |
| 90 | MAPKAPK5 | 0.60640746 |
| 91 | PRKCI | 0.59808297 |
| 92 | MAP3K8 | 0.58222819 |
| 93 | RIPK1 | 0.58189218 |
| 94 | MAP3K11 | 0.57095260 |
| 95 | RET | 0.56951181 |
| 96 | MAPK12 | 0.56875632 |
| 97 | CSNK1E | 0.56162002 |
| 98 | CSNK2A2 | 0.55992712 |
| 99 | JAK1 | 0.55990333 |
| 100 | AKT2 | 0.55863691 |
| 101 | TBK1 | 0.55847090 |
| 102 | BMPR2 | 0.55597161 |
| 103 | STK24 | 0.54879407 |
| 104 | RPS6KB1 | 0.54291346 |
| 105 | CDK4 | 0.54034725 |
| 106 | TESK2 | 0.53949756 |
| 107 | AURKA | 0.52751708 |
| 108 | IRAK3 | 0.49857981 |
| 109 | CDK6 | 0.48702528 |
| 110 | PAK4 | 0.47994338 |
| 111 | MAP2K6 | 0.47076362 |
| 112 | CSK | 0.46903540 |
| 113 | ALK | 0.45743526 |
| 114 | ATR | 0.45733915 |
| 115 | CAMK2G | 0.45280054 |
| 116 | PLK1 | 0.43233385 |
| 117 | STK10 | 0.42257391 |
| 118 | ILK | 0.41957839 |
| 119 | CSNK2A1 | 0.41477694 |
| 120 | MAP3K1 | 0.41428439 |
| 121 | WNK1 | 0.41283016 |
| 122 | AURKB | 0.41168334 |
| 123 | CHEK2 | 0.40528948 |
| 124 | PDK1 | 0.38694075 |
| 125 | LRRK2 | 0.36676402 |
| 126 | PAK3 | 0.36642249 |
| 127 | RAF1 | 0.36122343 |
| 128 | PRKG2 | 0.34210090 |
| 129 | CHEK1 | 0.34020932 |
| 130 | KSR2 | 0.33826045 |
| 131 | IRAK2 | 0.33170073 |
| 132 | CAMK1D | 0.33064589 |
| 133 | PRKCQ | 0.32738952 |
| 134 | CSNK1G1 | 0.32369577 |
| 135 | MATK | 0.32026255 |
| 136 | EPHA4 | 0.30155965 |
| 137 | TAOK2 | 0.28980448 |
| 138 | IGF1R | 0.28896214 |
| 139 | BCR | 0.27760702 |
| 140 | MTOR | 0.27587856 |
| 141 | MAPK7 | 0.27499100 |
| 142 | FGFR3 | 0.27264633 |
| 143 | PRKCG | 0.26249141 |
| 144 | SGK1 | 0.24736871 |
| 145 | PRKCA | 0.24719113 |
| 146 | MAP3K2 | 0.24271988 |
| 147 | EPHA3 | 0.23576615 |
| 148 | MAP3K6 | 0.23449539 |
| 149 | MAP2K1 | 0.23343287 |
| 150 | IRAK1 | 0.23163454 |
| 151 | CAMK4 | 0.22982982 |
| 152 | MAP3K5 | 0.21635566 |
| 153 | GRK1 | 0.20959168 |
| 154 | FER | 0.20917011 |
| 155 | EGFR | 0.18490495 |
| 156 | IKBKE | 0.18482142 |
| 157 | BMX | 0.17685135 |
| 158 | CSF1R | 0.17181305 |
| 159 | PRKCD | 0.16433254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.89748455 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.50858142 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.13216289 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.12254067 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.93071725 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.74535099 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.74194058 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73588335 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.69831034 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64025155 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.58659058 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.54499313 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50728791 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.36594049 |
| 15 | * Peroxisome_Homo sapiens_hsa04146 | 2.24270703 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.20996475 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.12614071 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.01321556 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.93261488 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93013846 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.88721722 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76402610 |
| 23 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74632895 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.72274667 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71024406 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70308831 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70224466 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.68432669 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64708600 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.63711742 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61653493 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57070696 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56024263 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53315905 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50853231 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.48178037 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43858415 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.33862296 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.33728850 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30770502 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28557696 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27515868 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.27464491 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25135096 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24613990 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22592784 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21261492 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19533705 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12370781 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11701352 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.05136281 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.03180836 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 1.01443555 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96245483 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94052332 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93512714 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90163639 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85170636 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84298498 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83412361 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78004949 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77008873 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66094278 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60982405 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59823427 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51073633 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41734707 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32709672 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24351977 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22843162 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21734635 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19885272 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19513095 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.13748233 |
| 75 | * Insulin resistance_Homo sapiens_hsa04931 | 0.12892592 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.11405420 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.10647275 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.09340780 |
| 79 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.07460253 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07225836 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.07222074 |
| 82 | DNA replication_Homo sapiens_hsa03030 | 0.06134953 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.06076758 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.05832070 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.04810530 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.04363481 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.04262712 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02299523 |
| 89 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.02154907 |
| 90 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.01542189 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00798779 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.00726418 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00088890 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1876158 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1837216 |
| 96 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1632050 |
| 97 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.1615502 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1532882 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | -0.1506658 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1465532 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1460465 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1379934 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | -0.1226561 |
| 104 | Base excision repair_Homo sapiens_hsa03410 | -0.1139407 |
| 105 | Lysosome_Homo sapiens_hsa04142 | -0.0943676 |
| 106 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | -0.0681199 |
| 107 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0679923 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0608164 |
| 109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0520494 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0359528 |
| 111 | Mismatch repair_Homo sapiens_hsa03430 | -0.0344716 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0213015 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0111187 |
| 114 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0037113 |

